Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research ...

A new, generic, non-steroidal anti-inflammatory drug (NSAID) is now available for managing osteoarthritis (OA) pain in horses ...

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Secretary Robert F. Kennedy Jr. says he has a “generic list” of people he wants removed from his department. “I have a list ...

Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...

The Association for Accessible Medicines argued that a California law was trying to regulate business outside state borders.

California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...

Olympus Partners has acquired PAI Pharma, a US-based manufacturer of generic oral liquids. No financial terms were disclosed. Kurt Orlofski serves as CEO of PAI. PAI Pharma has two large manufacturing ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key ...